| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-06 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-06 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.12 | 2e-05 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-05 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |